Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPersonalized MedicinePivotal Practice Views with the Oncology BrothersPodcastsSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

Advanced Lung Cancer

home / expert-perspective-tumor-board / advanced-lung-cancer

Case 1: Locally Advanced NSCLC

EP. 1: Case 1: Locally Advanced NSCLC

June 14th 2019

Watch


Case 1: Radiation Therapy for Locally Advanced NSCLC

EP. 2: Case 1: Radiation Therapy for Locally Advanced NSCLC

June 14th 2019

Watch


Case 1: Molecular Testing in Locally Advanced NSCLC

EP. 3: Case 1: Molecular Testing in Locally Advanced NSCLC

June 14th 2019

Watch


Case 1: Surgery and Chemotherapy in Locally Advanced NSCLC

EP. 4: Case 1: Surgery and Chemotherapy in Locally Advanced NSCLC

June 14th 2019

Watch


Case 1: Immunotherapy in Locally Advanced NSCLC

EP. 5: Case 1: Immunotherapy in Locally Advanced NSCLC

June 14th 2019

Watch


Case 2: PD-L1+ and EGFR+ Lung Adenocarcinoma

EP. 6: Case 2: PD-L1+ and EGFR+ Lung Adenocarcinoma

June 14th 2019

Watch


Case 2: Diagnosing PD-L1+ and EGFR+ Lung Adenocarcinoma

EP. 7: Case 2: Diagnosing PD-L1+ and EGFR+ Lung Adenocarcinoma

June 14th 2019

Watch


Case 2: Testing for EGFR in Lung Adenocarcinoma

EP. 8: Case 2: Testing for EGFR in Lung Adenocarcinoma

June 14th 2019

Watch


Case 2: Frontline Therapy in EGFR-Mutated Lung Cancer

EP. 9: Case 2: Frontline Therapy in EGFR-Mutated Lung Cancer

June 14th 2019

Watch


Case 2: Osimertinib in EGFR-Mutated Lung Cancer

EP. 10: Case 2: Osimertinib in EGFR-Mutated Lung Cancer

June 14th 2019

Watch


Case 3: Extensive-Stage SCLC

EP. 11: Case 3: Extensive-Stage SCLC

June 14th 2019

Watch


Case 3: Pathology Considerations in SCLC

EP. 12: Case 3: Pathology Considerations in SCLC

June 14th 2019

Watch


Case 3: Chemoimmunotherapy in SCLC

EP. 13: Case 3: Chemoimmunotherapy in SCLC

June 14th 2019

Watch


Case 4: Stage IV Adenocarcinoma Without Genetic Driver

EP. 14: Case 4: Stage IV Adenocarcinoma Without Genetic Driver

June 14th 2019

Watch


Case 4: SRS Versus Whole Brain Radiation Therapy

EP. 15: Case 4: SRS Versus Whole Brain Radiation Therapy

June 14th 2019

Watch


Case 4: I-O Combination Regimens in Stage IV NSCLC

EP. 16: Case 4: I-O Combination Regimens in Stage IV NSCLC

June 14th 2019

Watch


Case 4: Treating Stage IV NSCLC With Novel Approaches

EP. 17: Case 4: Treating Stage IV NSCLC With Novel Approaches

June 14th 2019

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Editorial Board
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.